NCT04267380View on ClinicalTrials.gov

A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A Day

CompletedOBSERVATIONAL
Enrollment

298

Participants

Timeline

Start Date

September 30, 2018

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Arthritis Rheumatoid
Trial Locations (1)

10017

Pfizer, New York

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04267380 - A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A Day | Biotech Hunter | Biotech Hunter